Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04846322 · ClinicalTrials.gov registry record
Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 100
- Enrollment target
NCT04846322: Completed study, sponsored by Yale University.
NCT04846322 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04846322 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is an observational study of the pragmatic implementation of an ED screening, outpatient referral, and care coordination process for older ED patients who may have UCID.
Primary Outcome
percentage of patients discharged from ED positive for delirium or dementia among total number of patients 65+
Interventions
- DIAGNOSTIC_TEST PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2022-08-15 |
What the finished NCT04846322 record still lists
NCT04846322 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan) is the first listed.
NCT04846322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04846322 about?
NCT04846322 is a clinical study titled "Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department". This is an observational study of the pragmatic implementation of an ED screening, outpatient referral, and care coordination process for older ED patients who may have UCID.
What is the current status of trial NCT04846322?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-03-01. Estimated completion is 2022-08-15.
What interventions are being tested in trial NCT04846322?
The interventions under investigation include: PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04846322?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI